Serological screening for celiac disease in symptomatic 12 to 36 month-old children

Inês Cristina Modelli1, Lenora Gandolfi, Rodrigo Coutinho de Almeida

  • 1Graduate Program in Health Sciences, University of Brasilia School of Health Sciences, Brasilia, DF, Brazil.

Insights

Celiac disease affects 2.3% of young children with symptoms like diarrhea and failure to thrive. Diagnosis in this group is challenging, but serological tests and genetic analysis aid in identifying the condition.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Genetics

Background:

  • Diagnosing celiac disease in young children is difficult due to overlapping symptoms with malnutrition and diarrhea.
  • Environmental factors and other conditions can mimic celiac disease symptoms in children.

Purpose of the Study:

  • To determine the prevalence of celiac disease in children aged 12-36 months.
  • To evaluate the effectiveness of serological screening methods including immunoglobulin antibodies against gliadin (IgG and IgA-AGA), IgA-EMA, and IgA-tTG.

Main Methods:

  • 214 children (12-36 months) on a gluten-containing diet were screened using IgG/IgA-AGA, IgA-tTG, and IgA-EMA tests.
  • Biopsies were performed on children with positive serological results; HLA genotyping was used for confirmation and in ambiguous cases.
  • Polymerase chain reaction (PCR) HLA genotyping identified celiac disease predisposing alleles.

Main Results:

  • Five children were diagnosed with celiac disease based on positive serological tests and characteristic jejunal biopsy findings.
  • IgG-AGA alone was insufficient for diagnosis, but combined with HLA genotyping and biopsy, it contributed to identifying cases.
  • A prevalence of 2.3% was identified in the studied cohort of symptomatic, undiagnosed children.

Conclusions:

  • Celiac disease can be diagnosed in symptomatic young children using a combination of serological tests and genetic analysis.
  • The study highlights the importance of comprehensive diagnostic approaches for celiac disease in pediatric populations.
  • A 2.3% prevalence underscores the need for awareness and screening in this age group.
Abstract